Induction of macrophage death by clinical strains of Mycobacterium kansasii

Microbial Pathogenesis

Volumn 48, Issue 5, 2010, Pages 160-167

  Sohn, Hosung ^a   Kim, Kwang Wook ^a   Kang, Hyun Bae ^a   Won, Choul Jae ^a   Kim, Woo Sik ^a   Lee, Byungsoo ^a   Kwon, O Jung ^b   Koh, Won Jung ^b   Shin, Sung Jae ^a   Kim, Hwa Jung ^a  

^a Chungnam National University   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Macrophage; Mitochondrial permeability transition; Mycobacterium kansasii; Necrosis; Virulence

Indexed keywords

CYCLOSPORIN A; TUMOR NECROSIS FACTOR ALPHA;

ACUTE MONOCYTIC LEUKEMIA; ANIMAL CELL; APOPTOSIS; ARTICLE; BACTERIUM ISOLATION; BONE MARROW; CELL DEATH; CELL GROWTH; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; FEMALE; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; LEUKEMIA CELL; LUNG DISEASE; MACROPHAGE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL PERMEABILITY; MOUSE; MYCOBACTERIUM KANSASII; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; CASPASES; CELL LINE, TUMOR; CELLS, CULTURED; CYTOKINES; HUMANS; MACROPHAGES; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MYCOBACTERIUM KANSASII; NECROSIS; TUMOR NECROSIS FACTOR-ALPHA;

MYCOBACTERIUM KANSASII;

EID: 77952953736     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2010.02.005     Document Type: Article

References (25)

1. Falkinham J.O. Epidemiology of infection by nontuberculous mycobacteria. Clin Microbiol Rev 1996, 9:177-215.
2. Field S.K., Cowie R.L. Lung disease due to the more common nontuberculous mycobacteria. Chest 2006, 129:1653-1672.
3. Koh W.J., Yu C.M., Suh G.Y., Chung M.P., Kim H., Kwon O.J., et al. Pulmonary TB and NTM lung disease: comparison of characteristics in patients with AFB smear-positive sputum. Int J Tuberc Lung Dis 2006, 10:1001-1007.
4. Campo R.E., Campo C.E. Mycobacterium kansasii disease in patients infected with human immunodefiency virus. Clin Infect Dis 1997, 24:1233-1238.
5. Taillard C., Greub G., Weber R., Pfyffer G.E., Bodmer T., Zimmerli S., et al. Clinical implications of Mycobacterium kansasii species heterogeneity: Swiss national survey. J Clin Microbiol 2003, 41:1240-1244.
6. Arend S.M., Cerdá de Palou E., de Haas P., Janssen R., Hoeve M.A., Verhard E.M., et al. Pneumonia caused by Mycobacterium kansasii in a series of patients without recognised immune defect. Clin Microbiol Infect 2004, 10:738-748.
7. Santucci M.B., Amicosante M., Cicconi R., Montesano C., Casarini M., Giosuè S., et al. Mycobacterium tuberculosis-induced apoptosis in monocytes/macrophages: early membrane modifications and intracellular mycobacterial viability. J Infect Dis 2000, 181:1506-1509.
8. Duan L., Gan H., Golan D.E., Remold H.G. Critical role of mitochondrial damage in determining outcome of macrophage infection with Mycobacterium tuberculosis. J Immunol 2002, 169:5181-5187.
9. Danelishvili L., McGarvey J., Li Y.J., Bermudez L.E. Mycobacterium tuberculosis infection causes different levels of apoptosis and necrosis in human macrophages and alveolar epithelial cells. Cell Microbiol 2003, 5:649-660.
10. Schaible U.E., Winau F., Sieling P.A., Fischer K., Collins H.L., Hagens K., et al. Apoptosis facilitates antigen presentation to T lymphocytes through MHC-1 and CD1 in tuberculosis. Nat Med 2003, 9:1039-1046.
11. Park J.S., Tamayo M.H., Gonzalez-Juarrero M., Orme I.M., Ordway D.J. Virulent clinical isolates of Mycobacterium tuberculosis grow rapidly and induce cellular necrosis but minimal apoptosis in murine macrophages. J Leukoc Biol 2006, 79:80-86.
12. Keane J., Remold H.G., Kornfeld H. Virulent Mycobacterium tuberculosis evade apoptosis of infected alveolar macrphages. J Immunol 2000, 164:2016-2020.
13. Zhang J., Jiang R., Takayama H., Tanaka Y. Survival of virulent Mycobacterium tuberculosis involves preventing apoptosis induced by Bcl-2 upregulation and release resulting from necrosis in J774 macrophages. Microbial Immunol 2005, 49:845-852.
14. Sohn H., Lee K.S., Kim S.Y., Shin D.M., Shin S.J., Jo E.K., et al. Induction of cell death in human macrophages by a highly virulent Korean isolate of Mycobacterium tuberculosis and the virulent strain H37Rv. Scand J Immunol 2009, 69:43-50.
15. Chen M., Gan H., Remold H.G. A mechanism of virulence: virulent Mycobacterium tuberculosis strain H37Rv, but not attenuated H37Ra, causes significant mitochondrial inner membrane disruption in macrophages leading to necrosis. J Immunol 2006, 176:3707-3716.
16. Guérardel Y., Maes E., Briken V., Chirat F., Leroy Y., Locht C., et al. Lipomannan and lipoarabinomannan from a clinical isolate of Mycobacterium kansasii: novel structural features and apoptosis-inducing properties. J Biol Chem 2003, 278:36637-36651.
17. Silver R.F., Li Q., Ellner J.J. Expression of virulence of Mycobacterium tuberculosis within human monocytes: virulence correlates with intracellular growth and induction of tumor necrosis factor alpha but not with evasion of lymphocyte-dependent monocyte effector functions. Infect Immun 1998, 66:1190-1199.
18. Zhang M., Gong J., Lin Y., Barnes P.F. Growth of virulent and avirulent Mycobacterium tuberculosis strains in human macrophages. Infect Immun 1998, 66:794-799.
19. Tateishi Y., Hirayama Y., Ozeki Y., Nishiuchi Y., Yoshimura M., Kang J., et al. Virulence of Mycobacterium avium complex strains isolated from immunocompetent patients. Microb Pathog 2009, 46:6-12.
20. Theus S., Eisenach K., Fomukong N., Silver R.F., Cave M.D. Beijing family Mycobacterium tuberculosis strains differ in their intracellular growth in THP-1 macrophages. Int J Tuberc Lung Dis 2007, 11:1087-1093.
21. Lee J., Remold H.G., Ieong M.H., Kornfeld H. Macrophage apoptosis in response to high intracellular burden of Mycobacterium tuberculosis is mediated by a novel caspase-independent pathway. J Immunol 2006, 176:4267-4274.
22. Keane J., Balcewicz-Sablinska M.K., Remold H.G., Chupp G.L., Meek B.B., Fenton M.J., et al. Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis. Infect Immun 1997, 65:298-304.
23. Mendelson M., Walters S., Smith I., Kaplan G. Strain-specific mycobacterial lipids and the stimulation of protective immunity to tuberculosis. Tuberculosis 2005, 85:407-413.
24. Griffith D.E., Aksamit T., Brown-Elliott B.A., Catanzaro A., Daley C., Gordin F., et al. ATS Mycobacterial Diseases Subcommittee; American Thoracic Society; Infectious Disease Society of America. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007, 175:367-416.
25. Kim H.Y., Kook Y., Yun Y.J., Park C.G., Lee N.Y., Shim T.S., et al. Proportions of Mycobacterium massiliense and Mycobacterium bolletii strains among Korean Mycobacterium chelonae- Mycobacterium abscessus group isolates. J Clin Microbiol 2008, 46:3384-3390.